BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 75 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 800,000 | $4,040,000 | 4.89% |
CVI Holdings, LLC | 750,000 | $3,787,500 | 3.98% |
NEA Management Company, LLC | 4,448,757 | $22,466,223 | 1.72% |
CHI Advisors LLC | 750,000 | $3,787,500 | 1.15% |
Bellevue Group AG | 8,135,839 | $41,085,987 | 0.59% |
Boxer Capital, LLC | 2,014,858 | $10,175 | 0.47% |
Ikarian Capital, LLC | 545,103 | $2,752,770 | 0.44% |
Parkman Healthcare Partners LLC | 500,000 | $2,525,000 | 0.44% |
RA Capital Management | 3,525,754 | $17,805,058 | 0.34% |
Opaleye Management Inc. | 275,000 | $1,388,750 | 0.33% |
Artal Group S.A. | 2,046,517 | $10,335 | 0.32% |
VR Adviser, LLC | 353,629 | $1,785,826 | 0.29% |
Soleus Capital Management, L.P. | 435,000 | $2,196,750 | 0.24% |
Newtyn Management, LLC | 200,000 | $1,010,000 | 0.24% |
Monashee Investment Management LLC | 170,000 | $858,500 | 0.20% |
EAM Investors, LLC | 207,428 | $1,047,511 | 0.19% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,000 | $9,090,000 | 0.19% |
Eversept Partners, LP | 427,317 | $2,157,951 | 0.18% |
RTW INVESTMENTS, LP | 1,700,000 | $8,585,000 | 0.16% |
KENNEDY CAPITAL MANAGEMENT LLC | 751,403 | $3,794,585 | 0.09% |
External links
This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q2 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.